nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO1B3—Docetaxel—stomach cancer	0.158	0.199	CbGbCtD
Fexofenadine—ABCB1—Mitomycin—stomach cancer	0.14	0.177	CbGbCtD
Fexofenadine—SLCO1B1—Irinotecan—stomach cancer	0.126	0.158	CbGbCtD
Fexofenadine—SLCO1B3—Methotrexate—stomach cancer	0.114	0.144	CbGbCtD
Fexofenadine—SLCO1A2—Methotrexate—stomach cancer	0.0705	0.0887	CbGbCtD
Fexofenadine—SLCO1B1—Methotrexate—stomach cancer	0.0665	0.0837	CbGbCtD
Fexofenadine—ABCB1—Irinotecan—stomach cancer	0.036	0.0453	CbGbCtD
Fexofenadine—ABCB1—Docetaxel—stomach cancer	0.0264	0.0332	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—stomach cancer	0.0197	0.0247	CbGbCtD
Fexofenadine—ABCB1—Methotrexate—stomach cancer	0.0191	0.024	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—stomach cancer	0.0185	0.0233	CbGbCtD
Fexofenadine—SLCO1B1—hematopoietic system—stomach cancer	0.00156	0.0655	CbGeAlD
Fexofenadine—SLCO1B3—endocrine gland—stomach cancer	0.00155	0.0651	CbGeAlD
Fexofenadine—SLCO1B3—liver—stomach cancer	0.0014	0.0587	CbGeAlD
Fexofenadine—SLCO2B1—hematopoietic system—stomach cancer	0.00138	0.0579	CbGeAlD
Fexofenadine—SLCO1A2—hematopoietic system—stomach cancer	0.00127	0.0533	CbGeAlD
Fexofenadine—SLCO1B1—digestive system—stomach cancer	0.00109	0.0456	CbGeAlD
Fexofenadine—SLCO2B1—digestive system—stomach cancer	0.000961	0.0403	CbGeAlD
Fexofenadine—SLCO1B1—endocrine gland—stomach cancer	0.000898	0.0376	CbGeAlD
Fexofenadine—SLCO1A2—digestive system—stomach cancer	0.000884	0.0371	CbGeAlD
Fexofenadine—Otitis media—Doxorubicin—stomach cancer	0.000829	0.00591	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Docetaxel—stomach cancer	0.000828	0.0059	CcSEcCtD
Fexofenadine—Dizziness—Mitomycin—stomach cancer	0.000812	0.00579	CcSEcCtD
Fexofenadine—SLCO1B1—liver—stomach cancer	0.000809	0.0339	CbGeAlD
Fexofenadine—ABCB1—blood vessel—stomach cancer	0.0008	0.0335	CbGeAlD
Fexofenadine—SLCO2B1—endocrine gland—stomach cancer	0.000794	0.0333	CbGeAlD
Fexofenadine—Atrial fibrillation—Docetaxel—stomach cancer	0.000792	0.00564	CcSEcCtD
Fexofenadine—Vomiting—Mitomycin—stomach cancer	0.000781	0.00557	CcSEcCtD
Fexofenadine—HRH1—hematopoietic system—stomach cancer	0.000778	0.0326	CbGeAlD
Fexofenadine—Rash—Mitomycin—stomach cancer	0.000775	0.00552	CcSEcCtD
Fexofenadine—Dermatitis—Mitomycin—stomach cancer	0.000774	0.00551	CcSEcCtD
Fexofenadine—Increased appetite—Capecitabine—stomach cancer	0.000773	0.00551	CcSEcCtD
Fexofenadine—Viral infection—Epirubicin—stomach cancer	0.000772	0.0055	CcSEcCtD
Fexofenadine—Headache—Mitomycin—stomach cancer	0.00077	0.00548	CcSEcCtD
Fexofenadine—Atrial fibrillation—Capecitabine—stomach cancer	0.000767	0.00546	CcSEcCtD
Fexofenadine—Thirst—Capecitabine—stomach cancer	0.000763	0.00544	CcSEcCtD
Fexofenadine—Epistaxis—Fluorouracil—stomach cancer	0.000756	0.00539	CcSEcCtD
Fexofenadine—Sinusitis—Fluorouracil—stomach cancer	0.000752	0.00536	CcSEcCtD
Fexofenadine—Pain in extremity—Docetaxel—stomach cancer	0.00075	0.00535	CcSEcCtD
Fexofenadine—SLCO1A2—endocrine gland—stomach cancer	0.000731	0.0306	CbGeAlD
Fexofenadine—Nausea—Mitomycin—stomach cancer	0.00073	0.0052	CcSEcCtD
Fexofenadine—Pain in extremity—Capecitabine—stomach cancer	0.000727	0.00518	CcSEcCtD
Fexofenadine—SLCO2B1—liver—stomach cancer	0.000716	0.03	CbGeAlD
Fexofenadine—Viral infection—Doxorubicin—stomach cancer	0.000714	0.00509	CcSEcCtD
Fexofenadine—HRH1—epithelium—stomach cancer	0.000711	0.0298	CbGeAlD
Fexofenadine—Flushing—Irinotecan—stomach cancer	0.000697	0.00497	CcSEcCtD
Fexofenadine—HRH1—smooth muscle tissue—stomach cancer	0.000685	0.0287	CbGeAlD
Fexofenadine—Nasopharyngitis—Docetaxel—stomach cancer	0.000671	0.00478	CcSEcCtD
Fexofenadine—SLCO1A2—liver—stomach cancer	0.000659	0.0276	CbGeAlD
Fexofenadine—Nasopharyngitis—Capecitabine—stomach cancer	0.00065	0.00463	CcSEcCtD
Fexofenadine—Flatulence—Irinotecan—stomach cancer	0.000644	0.00459	CcSEcCtD
Fexofenadine—Dry eye—Epirubicin—stomach cancer	0.000644	0.00459	CcSEcCtD
Fexofenadine—Back pain—Irinotecan—stomach cancer	0.000632	0.00451	CcSEcCtD
Fexofenadine—Abdominal discomfort—Capecitabine—stomach cancer	0.000602	0.00429	CcSEcCtD
Fexofenadine—Dry eye—Doxorubicin—stomach cancer	0.000596	0.00425	CcSEcCtD
Fexofenadine—CYP2D6—hematopoietic system—stomach cancer	0.000592	0.0248	CbGeAlD
Fexofenadine—Vision blurred—Fluorouracil—stomach cancer	0.00059	0.0042	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000584	0.00416	CcSEcCtD
Fexofenadine—Cough—Irinotecan—stomach cancer	0.000571	0.00407	CcSEcCtD
Fexofenadine—Fluspirilene—ADRB1—stomach cancer	0.000567	0.39	CrCbGaD
Fexofenadine—Cardiac failure congestive—Epirubicin—stomach cancer	0.000558	0.00398	CcSEcCtD
Fexofenadine—SLCO2B1—lymph node—stomach cancer	0.000549	0.023	CbGeAlD
Fexofenadine—Epistaxis—Docetaxel—stomach cancer	0.000546	0.00389	CcSEcCtD
Fexofenadine—HRH1—digestive system—stomach cancer	0.000541	0.0227	CbGeAlD
Fexofenadine—Increased appetite—Epirubicin—stomach cancer	0.000539	0.00384	CcSEcCtD
Fexofenadine—Anaphylactic shock—Irinotecan—stomach cancer	0.000534	0.0038	CcSEcCtD
Fexofenadine—Myalgia—Fluorouracil—stomach cancer	0.000533	0.0038	CcSEcCtD
Fexofenadine—Infection—Irinotecan—stomach cancer	0.00053	0.00378	CcSEcCtD
Fexofenadine—Epistaxis—Capecitabine—stomach cancer	0.000528	0.00376	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Doxorubicin—stomach cancer	0.000516	0.00368	CcSEcCtD
Fexofenadine—Anaphylactic shock—Fluorouracil—stomach cancer	0.000511	0.00364	CcSEcCtD
Fexofenadine—Infection—Fluorouracil—stomach cancer	0.000508	0.00362	CcSEcCtD
Fexofenadine—Fluspirilene—HTR1A—stomach cancer	0.000507	0.349	CrCbGaD
Fexofenadine—Pain in extremity—Epirubicin—stomach cancer	0.000506	0.00361	CcSEcCtD
Fexofenadine—Tachycardia—Fluorouracil—stomach cancer	0.000499	0.00355	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—stomach cancer	0.000499	0.00355	CcSEcCtD
Fexofenadine—Insomnia—Irinotecan—stomach cancer	0.000483	0.00344	CcSEcCtD
Fexofenadine—Flushing—Docetaxel—stomach cancer	0.000482	0.00343	CcSEcCtD
Fexofenadine—Dyspnoea—Irinotecan—stomach cancer	0.000476	0.00339	CcSEcCtD
Fexofenadine—Somnolence—Irinotecan—stomach cancer	0.000474	0.00338	CcSEcCtD
Fexofenadine—Dyspepsia—Irinotecan—stomach cancer	0.00047	0.00335	CcSEcCtD
Fexofenadine—Pain in extremity—Doxorubicin—stomach cancer	0.000468	0.00334	CcSEcCtD
Fexofenadine—Flushing—Capecitabine—stomach cancer	0.000467	0.00332	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000466	0.00332	CcSEcCtD
Fexofenadine—Insomnia—Fluorouracil—stomach cancer	0.000462	0.00329	CcSEcCtD
Fexofenadine—Fatigue—Irinotecan—stomach cancer	0.00046	0.00328	CcSEcCtD
Fexofenadine—Pain—Irinotecan—stomach cancer	0.000456	0.00325	CcSEcCtD
Fexofenadine—Dyspnoea—Fluorouracil—stomach cancer	0.000456	0.00325	CcSEcCtD
Fexofenadine—Somnolence—Fluorouracil—stomach cancer	0.000454	0.00324	CcSEcCtD
Fexofenadine—Nasopharyngitis—Epirubicin—stomach cancer	0.000453	0.00323	CcSEcCtD
Fexofenadine—Dyspepsia—Fluorouracil—stomach cancer	0.00045	0.00321	CcSEcCtD
Fexofenadine—Abdominal discomfort—Methotrexate—stomach cancer	0.000448	0.00319	CcSEcCtD
Fexofenadine—HRH1—endocrine gland—stomach cancer	0.000447	0.0188	CbGeAlD
Fexofenadine—Back pain—Docetaxel—stomach cancer	0.000437	0.00312	CcSEcCtD
Fexofenadine—Pain—Fluorouracil—stomach cancer	0.000437	0.00311	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Irinotecan—stomach cancer	0.000436	0.00311	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000435	0.0031	CcSEcCtD
Fexofenadine—Flatulence—Capecitabine—stomach cancer	0.000431	0.00307	CcSEcCtD
Fexofenadine—ABCB1—hematopoietic system—stomach cancer	0.000426	0.0179	CbGeAlD
Fexofenadine—Back pain—Capecitabine—stomach cancer	0.000423	0.00302	CcSEcCtD
Fexofenadine—Body temperature increased—Irinotecan—stomach cancer	0.000422	0.00301	CcSEcCtD
Fexofenadine—Abdominal pain—Irinotecan—stomach cancer	0.000422	0.00301	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—stomach cancer	0.000419	0.00298	CcSEcCtD
Fexofenadine—Drowsiness—Methotrexate—stomach cancer	0.000417	0.00297	CcSEcCtD
Fexofenadine—Vision blurred—Capecitabine—stomach cancer	0.000412	0.00294	CcSEcCtD
Fexofenadine—CYP2D6—digestive system—stomach cancer	0.000412	0.0173	CbGeAlD
Fexofenadine—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000407	0.0029	CcSEcCtD
Fexofenadine—Urticaria—Fluorouracil—stomach cancer	0.000406	0.00289	CcSEcCtD
Fexofenadine—Pollakiuria—Epirubicin—stomach cancer	0.000404	0.00288	CcSEcCtD
Fexofenadine—Body temperature increased—Fluorouracil—stomach cancer	0.000404	0.00288	CcSEcCtD
Fexofenadine—Palpitations—Docetaxel—stomach cancer	0.000399	0.00285	CcSEcCtD
Fexofenadine—Cough—Docetaxel—stomach cancer	0.000394	0.00281	CcSEcCtD
Fexofenadine—Epistaxis—Methotrexate—stomach cancer	0.000393	0.0028	CcSEcCtD
Fexofenadine—Hypersensitivity—Irinotecan—stomach cancer	0.000393	0.0028	CcSEcCtD
Fexofenadine—Drowsiness—Epirubicin—stomach cancer	0.00039	0.00278	CcSEcCtD
Fexofenadine—ABCB1—epithelium—stomach cancer	0.000389	0.0163	CbGeAlD
Fexofenadine—Palpitations—Capecitabine—stomach cancer	0.000387	0.00276	CcSEcCtD
Fexofenadine—Myalgia—Docetaxel—stomach cancer	0.000385	0.00274	CcSEcCtD
Fexofenadine—Asthenia—Irinotecan—stomach cancer	0.000383	0.00273	CcSEcCtD
Fexofenadine—Cough—Capecitabine—stomach cancer	0.000382	0.00272	CcSEcCtD
Fexofenadine—Pimozide—HTR1A—stomach cancer	0.000379	0.261	CrCbGaD
Fexofenadine—Hypersensitivity—Fluorouracil—stomach cancer	0.000377	0.00268	CcSEcCtD
Fexofenadine—Dry mouth—Docetaxel—stomach cancer	0.000376	0.00268	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000376	0.00268	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—stomach cancer	0.000374	0.00266	CcSEcCtD
Fexofenadine—Myalgia—Capecitabine—stomach cancer	0.000373	0.00265	CcSEcCtD
Fexofenadine—Anaphylactic shock—Docetaxel—stomach cancer	0.000369	0.00263	CcSEcCtD
Fexofenadine—Epistaxis—Epirubicin—stomach cancer	0.000368	0.00262	CcSEcCtD
Fexofenadine—Infection—Docetaxel—stomach cancer	0.000366	0.00261	CcSEcCtD
Fexofenadine—Sinusitis—Epirubicin—stomach cancer	0.000366	0.00261	CcSEcCtD
Fexofenadine—Diarrhoea—Irinotecan—stomach cancer	0.000365	0.0026	CcSEcCtD
Fexofenadine—Dry mouth—Capecitabine—stomach cancer	0.000364	0.0026	CcSEcCtD
Fexofenadine—Pruritus—Fluorouracil—stomach cancer	0.000362	0.00258	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—stomach cancer	0.000361	0.00257	CcSEcCtD
Fexofenadine—Tachycardia—Docetaxel—stomach cancer	0.00036	0.00257	CcSEcCtD
Fexofenadine—Infection—Capecitabine—stomach cancer	0.000355	0.00253	CcSEcCtD
Fexofenadine—Dizziness—Irinotecan—stomach cancer	0.000353	0.00251	CcSEcCtD
Fexofenadine—Diarrhoea—Fluorouracil—stomach cancer	0.00035	0.00249	CcSEcCtD
Fexofenadine—Tachycardia—Capecitabine—stomach cancer	0.000349	0.00248	CcSEcCtD
Fexofenadine—ABCB1—pancreas—stomach cancer	0.000347	0.0145	CbGeAlD
Fexofenadine—Epistaxis—Doxorubicin—stomach cancer	0.00034	0.00243	CcSEcCtD
Fexofenadine—CYP2D6—endocrine gland—stomach cancer	0.00034	0.0143	CbGeAlD
Fexofenadine—Vomiting—Irinotecan—stomach cancer	0.000339	0.00242	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—stomach cancer	0.000339	0.00241	CcSEcCtD
Fexofenadine—Dizziness—Fluorouracil—stomach cancer	0.000338	0.00241	CcSEcCtD
Fexofenadine—Rash—Irinotecan—stomach cancer	0.000336	0.0024	CcSEcCtD
Fexofenadine—Dermatitis—Irinotecan—stomach cancer	0.000336	0.0024	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000336	0.00239	CcSEcCtD
Fexofenadine—Headache—Irinotecan—stomach cancer	0.000334	0.00238	CcSEcCtD
Fexofenadine—Insomnia—Docetaxel—stomach cancer	0.000334	0.00238	CcSEcCtD
Fexofenadine—Dyspnoea—Docetaxel—stomach cancer	0.000329	0.00234	CcSEcCtD
Fexofenadine—Somnolence—Docetaxel—stomach cancer	0.000328	0.00234	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000325	0.00232	CcSEcCtD
Fexofenadine—Flushing—Epirubicin—stomach cancer	0.000325	0.00232	CcSEcCtD
Fexofenadine—Vomiting—Fluorouracil—stomach cancer	0.000325	0.00232	CcSEcCtD
Fexofenadine—Dyspepsia—Docetaxel—stomach cancer	0.000325	0.00231	CcSEcCtD
Fexofenadine—Insomnia—Capecitabine—stomach cancer	0.000323	0.0023	CcSEcCtD
Fexofenadine—Rash—Fluorouracil—stomach cancer	0.000322	0.0023	CcSEcCtD
Fexofenadine—Dermatitis—Fluorouracil—stomach cancer	0.000322	0.00229	CcSEcCtD
Fexofenadine—Headache—Fluorouracil—stomach cancer	0.00032	0.00228	CcSEcCtD
Fexofenadine—Dyspnoea—Capecitabine—stomach cancer	0.000318	0.00227	CcSEcCtD
Fexofenadine—Fatigue—Docetaxel—stomach cancer	0.000318	0.00227	CcSEcCtD
Fexofenadine—Nausea—Irinotecan—stomach cancer	0.000317	0.00226	CcSEcCtD
Fexofenadine—Pain—Docetaxel—stomach cancer	0.000315	0.00225	CcSEcCtD
Fexofenadine—Back pain—Methotrexate—stomach cancer	0.000315	0.00225	CcSEcCtD
Fexofenadine—Dyspepsia—Capecitabine—stomach cancer	0.000314	0.00224	CcSEcCtD
Fexofenadine—HRH1—lymph node—stomach cancer	0.000309	0.013	CbGeAlD
Fexofenadine—Fatigue—Capecitabine—stomach cancer	0.000308	0.00219	CcSEcCtD
Fexofenadine—Vision blurred—Methotrexate—stomach cancer	0.000307	0.00219	CcSEcCtD
Fexofenadine—CYP2D6—liver—stomach cancer	0.000307	0.0129	CbGeAlD
Fexofenadine—Pain—Capecitabine—stomach cancer	0.000305	0.00218	CcSEcCtD
Fexofenadine—Nausea—Fluorouracil—stomach cancer	0.000304	0.00216	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000302	0.00215	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—stomach cancer	0.000301	0.00214	CcSEcCtD
Fexofenadine—Flatulence—Epirubicin—stomach cancer	0.0003	0.00214	CcSEcCtD
Fexofenadine—ABCB1—lymphoid tissue—stomach cancer	0.0003	0.0126	CbGeAlD
Fexofenadine—Tension—Epirubicin—stomach cancer	0.000299	0.00213	CcSEcCtD
Fexofenadine—ABCB1—digestive system—stomach cancer	0.000296	0.0124	CbGeAlD
Fexofenadine—Nervousness—Epirubicin—stomach cancer	0.000296	0.00211	CcSEcCtD
Fexofenadine—Back pain—Epirubicin—stomach cancer	0.000295	0.0021	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000292	0.00208	CcSEcCtD
Fexofenadine—Abdominal pain—Docetaxel—stomach cancer	0.000292	0.00208	CcSEcCtD
Fexofenadine—Body temperature increased—Docetaxel—stomach cancer	0.000292	0.00208	CcSEcCtD
Fexofenadine—Vision blurred—Epirubicin—stomach cancer	0.000287	0.00205	CcSEcCtD
Fexofenadine—Cough—Methotrexate—stomach cancer	0.000284	0.00203	CcSEcCtD
Fexofenadine—Urticaria—Capecitabine—stomach cancer	0.000284	0.00202	CcSEcCtD
Fexofenadine—Body temperature increased—Capecitabine—stomach cancer	0.000282	0.00201	CcSEcCtD
Fexofenadine—Abdominal pain—Capecitabine—stomach cancer	0.000282	0.00201	CcSEcCtD
Fexofenadine—Agitation—Epirubicin—stomach cancer	0.00028	0.002	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—stomach cancer	0.000278	0.00198	CcSEcCtD
Fexofenadine—Myalgia—Methotrexate—stomach cancer	0.000277	0.00198	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—stomach cancer	0.000277	0.00197	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—stomach cancer	0.000274	0.00195	CcSEcCtD
Fexofenadine—ABCB1—bone marrow—stomach cancer	0.000273	0.0114	CbGeAlD
Fexofenadine—Back pain—Doxorubicin—stomach cancer	0.000273	0.00194	CcSEcCtD
Fexofenadine—Hypersensitivity—Docetaxel—stomach cancer	0.000272	0.00194	CcSEcCtD
Fexofenadine—Palpitations—Epirubicin—stomach cancer	0.000269	0.00192	CcSEcCtD
Fexofenadine—Cough—Epirubicin—stomach cancer	0.000266	0.0019	CcSEcCtD
Fexofenadine—Anaphylactic shock—Methotrexate—stomach cancer	0.000266	0.00189	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—stomach cancer	0.000266	0.00189	CcSEcCtD
Fexofenadine—Asthenia—Docetaxel—stomach cancer	0.000265	0.00189	CcSEcCtD
Fexofenadine—Infection—Methotrexate—stomach cancer	0.000264	0.00188	CcSEcCtD
Fexofenadine—Hypersensitivity—Capecitabine—stomach cancer	0.000263	0.00187	CcSEcCtD
Fexofenadine—Pruritus—Docetaxel—stomach cancer	0.000261	0.00186	CcSEcCtD
Fexofenadine—Myalgia—Epirubicin—stomach cancer	0.00026	0.00185	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—stomach cancer	0.000259	0.00185	CcSEcCtD
Fexofenadine—Asthenia—Capecitabine—stomach cancer	0.000256	0.00183	CcSEcCtD
Fexofenadine—Dry mouth—Epirubicin—stomach cancer	0.000254	0.00181	CcSEcCtD
Fexofenadine—Pruritus—Capecitabine—stomach cancer	0.000253	0.0018	CcSEcCtD
Fexofenadine—Diarrhoea—Docetaxel—stomach cancer	0.000252	0.0018	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—stomach cancer	0.000249	0.00178	CcSEcCtD
Fexofenadine—Anaphylactic shock—Epirubicin—stomach cancer	0.000249	0.00177	CcSEcCtD
Fexofenadine—Infection—Epirubicin—stomach cancer	0.000247	0.00176	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—stomach cancer	0.000246	0.00175	CcSEcCtD
Fexofenadine—ABCB1—endocrine gland—stomach cancer	0.000245	0.0103	CbGeAlD
Fexofenadine—Diarrhoea—Capecitabine—stomach cancer	0.000244	0.00174	CcSEcCtD
Fexofenadine—Dizziness—Docetaxel—stomach cancer	0.000244	0.00174	CcSEcCtD
Fexofenadine—Tachycardia—Epirubicin—stomach cancer	0.000243	0.00173	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000242	0.00173	CcSEcCtD
Fexofenadine—Insomnia—Methotrexate—stomach cancer	0.00024	0.00171	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—stomach cancer	0.00024	0.00171	CcSEcCtD
Fexofenadine—Dyspnoea—Methotrexate—stomach cancer	0.000237	0.00169	CcSEcCtD
Fexofenadine—Somnolence—Methotrexate—stomach cancer	0.000236	0.00168	CcSEcCtD
Fexofenadine—Dizziness—Capecitabine—stomach cancer	0.000236	0.00168	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—stomach cancer	0.000235	0.00167	CcSEcCtD
Fexofenadine—Vomiting—Docetaxel—stomach cancer	0.000235	0.00167	CcSEcCtD
Fexofenadine—Dyspepsia—Methotrexate—stomach cancer	0.000234	0.00167	CcSEcCtD
Fexofenadine—Rash—Docetaxel—stomach cancer	0.000233	0.00166	CcSEcCtD
Fexofenadine—Dermatitis—Docetaxel—stomach cancer	0.000232	0.00166	CcSEcCtD
Fexofenadine—Headache—Docetaxel—stomach cancer	0.000231	0.00165	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—stomach cancer	0.00023	0.00164	CcSEcCtD
Fexofenadine—Fatigue—Methotrexate—stomach cancer	0.000229	0.00163	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—stomach cancer	0.000229	0.00163	CcSEcCtD
Fexofenadine—Pain—Methotrexate—stomach cancer	0.000227	0.00162	CcSEcCtD
Fexofenadine—Vomiting—Capecitabine—stomach cancer	0.000227	0.00162	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000227	0.00162	CcSEcCtD
Fexofenadine—Rash—Capecitabine—stomach cancer	0.000225	0.0016	CcSEcCtD
Fexofenadine—Insomnia—Epirubicin—stomach cancer	0.000225	0.0016	CcSEcCtD
Fexofenadine—Dermatitis—Capecitabine—stomach cancer	0.000225	0.0016	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—stomach cancer	0.000225	0.0016	CcSEcCtD
Fexofenadine—Headache—Capecitabine—stomach cancer	0.000224	0.00159	CcSEcCtD
Fexofenadine—Dyspnoea—Epirubicin—stomach cancer	0.000222	0.00158	CcSEcCtD
Fexofenadine—Somnolence—Epirubicin—stomach cancer	0.000221	0.00158	CcSEcCtD
Fexofenadine—ABCB1—liver—stomach cancer	0.000221	0.00925	CbGeAlD
Fexofenadine—Nausea—Docetaxel—stomach cancer	0.000219	0.00156	CcSEcCtD
Fexofenadine—Dyspepsia—Epirubicin—stomach cancer	0.000219	0.00156	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000217	0.00155	CcSEcCtD
Fexofenadine—Fatigue—Epirubicin—stomach cancer	0.000215	0.00153	CcSEcCtD
Fexofenadine—Pain—Epirubicin—stomach cancer	0.000213	0.00152	CcSEcCtD
Fexofenadine—Nausea—Capecitabine—stomach cancer	0.000212	0.00151	CcSEcCtD
Fexofenadine—Urticaria—Methotrexate—stomach cancer	0.000211	0.0015	CcSEcCtD
Fexofenadine—Abdominal pain—Methotrexate—stomach cancer	0.00021	0.0015	CcSEcCtD
Fexofenadine—Body temperature increased—Methotrexate—stomach cancer	0.00021	0.0015	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00021	0.00149	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—stomach cancer	0.000208	0.00148	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—stomach cancer	0.000205	0.00146	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—stomach cancer	0.000205	0.00146	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000203	0.00145	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—stomach cancer	0.000203	0.00144	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—stomach cancer	0.000198	0.00141	CcSEcCtD
Fexofenadine—Urticaria—Epirubicin—stomach cancer	0.000198	0.00141	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—stomach cancer	0.000197	0.0014	CcSEcCtD
Fexofenadine—Abdominal pain—Epirubicin—stomach cancer	0.000197	0.0014	CcSEcCtD
Fexofenadine—Body temperature increased—Epirubicin—stomach cancer	0.000197	0.0014	CcSEcCtD
Fexofenadine—Hypersensitivity—Methotrexate—stomach cancer	0.000196	0.0014	CcSEcCtD
Fexofenadine—Asthenia—Methotrexate—stomach cancer	0.000191	0.00136	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000188	0.00134	CcSEcCtD
Fexofenadine—Pruritus—Methotrexate—stomach cancer	0.000188	0.00134	CcSEcCtD
Fexofenadine—Hypersensitivity—Epirubicin—stomach cancer	0.000183	0.00131	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—stomach cancer	0.000183	0.0013	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—stomach cancer	0.000182	0.0013	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—stomach cancer	0.000182	0.0013	CcSEcCtD
Fexofenadine—Diarrhoea—Methotrexate—stomach cancer	0.000182	0.0013	CcSEcCtD
Fexofenadine—Asthenia—Epirubicin—stomach cancer	0.000179	0.00127	CcSEcCtD
Fexofenadine—Pruritus—Epirubicin—stomach cancer	0.000176	0.00125	CcSEcCtD
Fexofenadine—Dizziness—Methotrexate—stomach cancer	0.000176	0.00125	CcSEcCtD
Fexofenadine—Diarrhoea—Epirubicin—stomach cancer	0.00017	0.00121	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—stomach cancer	0.00017	0.00121	CcSEcCtD
Fexofenadine—ABCB1—lymph node—stomach cancer	0.000169	0.00709	CbGeAlD
Fexofenadine—Vomiting—Methotrexate—stomach cancer	0.000169	0.0012	CcSEcCtD
Fexofenadine—Rash—Methotrexate—stomach cancer	0.000168	0.00119	CcSEcCtD
Fexofenadine—Dermatitis—Methotrexate—stomach cancer	0.000167	0.00119	CcSEcCtD
Fexofenadine—Headache—Methotrexate—stomach cancer	0.000167	0.00119	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—stomach cancer	0.000165	0.00118	CcSEcCtD
Fexofenadine—Dizziness—Epirubicin—stomach cancer	0.000165	0.00117	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—stomach cancer	0.000163	0.00116	CcSEcCtD
Fexofenadine—Vomiting—Epirubicin—stomach cancer	0.000158	0.00113	CcSEcCtD
Fexofenadine—Nausea—Methotrexate—stomach cancer	0.000158	0.00113	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—stomach cancer	0.000158	0.00112	CcSEcCtD
Fexofenadine—Rash—Epirubicin—stomach cancer	0.000157	0.00112	CcSEcCtD
Fexofenadine—Dermatitis—Epirubicin—stomach cancer	0.000157	0.00112	CcSEcCtD
Fexofenadine—Headache—Epirubicin—stomach cancer	0.000156	0.00111	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—stomach cancer	0.000152	0.00108	CcSEcCtD
Fexofenadine—Nausea—Epirubicin—stomach cancer	0.000148	0.00105	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—stomach cancer	0.000146	0.00104	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—stomach cancer	0.000145	0.00103	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—stomach cancer	0.000145	0.00103	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—stomach cancer	0.000144	0.00103	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—stomach cancer	0.000137	0.000974	CcSEcCtD
Fexofenadine—ABCB1—Metabolism—PPAP2A—stomach cancer	2.46e-05	0.000625	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AGTR2—stomach cancer	2.43e-05	0.000618	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PGLS—stomach cancer	2.43e-05	0.000617	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—BLVRB—stomach cancer	2.43e-05	0.000617	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.42e-05	0.000615	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—ADRB1—stomach cancer	2.41e-05	0.000612	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—F2R—stomach cancer	2.4e-05	0.000611	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ENO1—stomach cancer	2.4e-05	0.000609	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.36e-05	0.000599	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HTR1A—stomach cancer	2.34e-05	0.000595	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPAP2A—stomach cancer	2.32e-05	0.000589	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPP2R1A—stomach cancer	2.3e-05	0.000585	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKAB1—stomach cancer	2.28e-05	0.00058	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	2.27e-05	0.000578	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ANXA1—stomach cancer	2.26e-05	0.000574	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTP1—stomach cancer	2.26e-05	0.000574	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.24e-05	0.00057	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—ALB—stomach cancer	2.24e-05	0.00057	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—HMOX1—stomach cancer	2.23e-05	0.000566	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KISS1—stomach cancer	2.2e-05	0.00056	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RNF43—stomach cancer	2.2e-05	0.00056	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NDUFA2—stomach cancer	2.19e-05	0.000557	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CA1—stomach cancer	2.19e-05	0.000557	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—FBP1—stomach cancer	2.19e-05	0.000557	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CKB—stomach cancer	2.19e-05	0.000557	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.19e-05	0.000557	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ADRB1—stomach cancer	2.19e-05	0.000556	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTT1—stomach cancer	2.19e-05	0.000556	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	2.16e-05	0.00055	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	2.16e-05	0.00055	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.16e-05	0.00055	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP2A6—stomach cancer	2.16e-05	0.00055	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CD44—stomach cancer	2.13e-05	0.00054	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.12e-05	0.000537	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKR1C3—stomach cancer	2.1e-05	0.000535	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—PIK3CA—stomach cancer	2.1e-05	0.000533	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—TYMS—stomach cancer	2.1e-05	0.000533	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTM1—stomach cancer	2.08e-05	0.000527	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CA1—stomach cancer	2.07e-05	0.000525	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—FBP1—stomach cancer	2.07e-05	0.000525	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NDUFA2—stomach cancer	2.07e-05	0.000525	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CKB—stomach cancer	2.07e-05	0.000525	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.06e-05	0.000524	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLIN2—stomach cancer	2.06e-05	0.000524	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ENO1—stomach cancer	2.05e-05	0.000521	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	2.04e-05	0.000519	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.02e-05	0.000512	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CA2—stomach cancer	2.01e-05	0.000509	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	2e-05	0.000509	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FST—stomach cancer	1.96e-05	0.000499	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NT5E—stomach cancer	1.95e-05	0.000496	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PGAM1—stomach cancer	1.95e-05	0.000496	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—ADRB2—stomach cancer	1.95e-05	0.000496	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ERCC2—stomach cancer	1.95e-05	0.000496	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLIN2—stomach cancer	1.94e-05	0.000493	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HBEGF—stomach cancer	1.92e-05	0.000488	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ALB—stomach cancer	1.92e-05	0.000487	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	1.91e-05	0.000486	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.91e-05	0.000485	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RGS2—stomach cancer	1.9e-05	0.000481	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GAST—stomach cancer	1.9e-05	0.000481	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CA2—stomach cancer	1.89e-05	0.00048	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	1.88e-05	0.000477	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALDH7A1—stomach cancer	1.86e-05	0.000474	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLCE1—stomach cancer	1.86e-05	0.000474	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.85e-05	0.00047	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PGAM1—stomach cancer	1.84e-05	0.000468	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NT5E—stomach cancer	1.84e-05	0.000468	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MTHFR—stomach cancer	1.83e-05	0.000466	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CD44—stomach cancer	1.82e-05	0.000462	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPP2R1A—stomach cancer	1.81e-05	0.000459	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.81e-05	0.000458	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGG—stomach cancer	1.8e-05	0.000456	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—UMPS—stomach cancer	1.79e-05	0.000454	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTP1—stomach cancer	1.77e-05	0.000451	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ADRB2—stomach cancer	1.77e-05	0.000451	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.76e-05	0.000448	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLCE1—stomach cancer	1.76e-05	0.000446	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALDH7A1—stomach cancer	1.76e-05	0.000446	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—HMOX1—stomach cancer	1.75e-05	0.000444	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PPP2R1A—stomach cancer	1.74e-05	0.000442	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	1.74e-05	0.000441	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKAA1—stomach cancer	1.73e-05	0.000439	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CAV1—stomach cancer	1.69e-05	0.00043	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—APOA1—stomach cancer	1.69e-05	0.000429	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—UMPS—stomach cancer	1.68e-05	0.000428	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RBP4—stomach cancer	1.67e-05	0.000424	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—CXCL8—stomach cancer	1.67e-05	0.000424	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.67e-05	0.000423	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	1.66e-05	0.000422	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PDHA1—stomach cancer	1.66e-05	0.000422	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ECHS1—stomach cancer	1.66e-05	0.000422	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—TYMS—stomach cancer	1.65e-05	0.000419	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTM1—stomach cancer	1.63e-05	0.000414	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.62e-05	0.00041	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.6e-05	0.000406	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.58e-05	0.0004	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ECHS1—stomach cancer	1.57e-05	0.000398	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PDHA1—stomach cancer	1.57e-05	0.000398	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TYMP—stomach cancer	1.56e-05	0.000397	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—FADS1—stomach cancer	1.56e-05	0.000397	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPP2R1A—stomach cancer	1.55e-05	0.000393	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.53e-05	0.000389	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ERCC2—stomach cancer	1.53e-05	0.000389	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTP1—stomach cancer	1.52e-05	0.000385	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.5e-05	0.000381	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.5e-05	0.000381	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—HMOX1—stomach cancer	1.5e-05	0.00038	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PPARG—stomach cancer	1.49e-05	0.000378	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TYMP—stomach cancer	1.47e-05	0.000374	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—FADS1—stomach cancer	1.47e-05	0.000374	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SREBF2—stomach cancer	1.46e-05	0.000372	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—RORA—stomach cancer	1.45e-05	0.000367	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MTHFR—stomach cancer	1.44e-05	0.000366	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HSPB1—stomach cancer	1.44e-05	0.000365	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AGTR2—stomach cancer	1.44e-05	0.000365	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.43e-05	0.000363	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BMP2—stomach cancer	1.42e-05	0.000361	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—F2R—stomach cancer	1.42e-05	0.000361	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.42e-05	0.00036	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—TYMS—stomach cancer	1.41e-05	0.000358	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKR1C3—stomach cancer	1.4e-05	0.000355	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—stomach cancer	1.39e-05	0.000354	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR1A—stomach cancer	1.38e-05	0.000351	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SREBF2—stomach cancer	1.38e-05	0.00035	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—RORA—stomach cancer	1.36e-05	0.000346	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALDOB—stomach cancer	1.35e-05	0.000344	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PRKCB—stomach cancer	1.34e-05	0.00034	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—stomach cancer	1.34e-05	0.00034	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ANXA1—stomach cancer	1.34e-05	0.000339	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CAV1—stomach cancer	1.33e-05	0.000338	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOA1—stomach cancer	1.33e-05	0.000337	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ERCC2—stomach cancer	1.31e-05	0.000333	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.3e-05	0.000331	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRB1—stomach cancer	1.29e-05	0.000329	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—NOS3—stomach cancer	1.28e-05	0.000325	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALDOB—stomach cancer	1.28e-05	0.000324	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.27e-05	0.000322	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALOX5—stomach cancer	1.26e-05	0.00032	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.26e-05	0.00032	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—DPYD—stomach cancer	1.24e-05	0.000315	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RPS6—stomach cancer	1.24e-05	0.000314	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—stomach cancer	1.23e-05	0.000313	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PRKCB—stomach cancer	1.22e-05	0.000309	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.21e-05	0.000308	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6ST—stomach cancer	1.21e-05	0.000308	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALOX5—stomach cancer	1.19e-05	0.000301	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—stomach cancer	1.17e-05	0.000297	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARG—stomach cancer	1.17e-05	0.000297	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—DPYD—stomach cancer	1.17e-05	0.000297	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CAV1—stomach cancer	1.14e-05	0.000289	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HBEGF—stomach cancer	1.14e-05	0.000288	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOA1—stomach cancer	1.13e-05	0.000288	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTT1—stomach cancer	1.1e-05	0.000278	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.09e-05	0.000276	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2A6—stomach cancer	1.08e-05	0.000275	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6R—stomach cancer	1.08e-05	0.000274	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—RHOA—stomach cancer	1.07e-05	0.000273	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKR1C3—stomach cancer	1.05e-05	0.000268	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—stomach cancer	1.05e-05	0.000267	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRB2—stomach cancer	1.05e-05	0.000266	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTT1—stomach cancer	1.03e-05	0.000262	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PPP2R1A—stomach cancer	1.03e-05	0.000261	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ENO1—stomach cancer	1.03e-05	0.000261	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.02e-05	0.000259	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—NOS3—stomach cancer	1e-05	0.000255	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARG—stomach cancer	9.99e-06	0.000254	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKR1C3—stomach cancer	9.93e-06	0.000252	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—RHOA—stomach cancer	9.76e-06	0.000248	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ENO1—stomach cancer	9.68e-06	0.000246	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	9.6e-06	0.000244	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SMAD4—stomach cancer	9.54e-06	0.000242	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—stomach cancer	9.43e-06	0.00024	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—stomach cancer	9.19e-06	0.000233	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CD44—stomach cancer	9.11e-06	0.000231	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FYN—stomach cancer	9.05e-06	0.00023	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—stomach cancer	8.98e-06	0.000228	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NOS3—stomach cancer	8.59e-06	0.000218	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CD44—stomach cancer	8.58e-06	0.000218	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—stomach cancer	8.57e-06	0.000218	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGFR2—stomach cancer	8.5e-06	0.000216	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—stomach cancer	7.86e-06	0.0002	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IRS2—stomach cancer	7.78e-06	0.000198	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPP2R1A—stomach cancer	7.74e-06	0.000197	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—stomach cancer	7.6e-06	0.000193	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CAV1—stomach cancer	7.55e-06	0.000192	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOA1—stomach cancer	7.53e-06	0.000191	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMOX1—stomach cancer	7.49e-06	0.00019	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	7.3e-06	0.000185	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—stomach cancer	7.2e-06	0.000183	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCB—stomach cancer	7.18e-06	0.000182	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—stomach cancer	7.16e-06	0.000182	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6ST—stomach cancer	7.15e-06	0.000182	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TYMS—stomach cancer	7.06e-06	0.000179	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMOX1—stomach cancer	7.06e-06	0.000179	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—stomach cancer	6.98e-06	0.000177	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APC—stomach cancer	6.87e-06	0.000175	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TYMS—stomach cancer	6.65e-06	0.000169	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAPK3—stomach cancer	6.58e-06	0.000167	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—stomach cancer	6.58e-06	0.000167	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ERCC2—stomach cancer	6.56e-06	0.000167	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6R—stomach cancer	6.38e-06	0.000162	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	6.26e-06	0.000159	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EGFR—stomach cancer	6.26e-06	0.000159	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ERCC2—stomach cancer	6.18e-06	0.000157	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—stomach cancer	6.17e-06	0.000157	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	5.99e-06	0.000152	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	5.98e-06	0.000152	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KRAS—stomach cancer	5.92e-06	0.00015	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—stomach cancer	5.81e-06	0.000148	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RHOA—stomach cancer	5.77e-06	0.000146	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOS3—stomach cancer	5.71e-06	0.000145	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CAV1—stomach cancer	5.69e-06	0.000145	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOA1—stomach cancer	5.68e-06	0.000144	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—stomach cancer	5.65e-06	0.000144	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	5.44e-06	0.000138	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CAV1—stomach cancer	5.36e-06	0.000136	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA1—stomach cancer	5.35e-06	0.000136	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB2—stomach cancer	5.34e-06	0.000136	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—stomach cancer	5.06e-06	0.000129	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HRAS—stomach cancer	5.03e-06	0.000128	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARG—stomach cancer	5e-06	0.000127	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	4.94e-06	0.000126	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—stomach cancer	4.84e-06	0.000123	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—stomach cancer	4.81e-06	0.000122	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCND1—stomach cancer	4.72e-06	0.00012	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARG—stomach cancer	4.71e-06	0.00012	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JUN—stomach cancer	4.71e-06	0.00012	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—stomach cancer	4.58e-06	0.000116	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	4.56e-06	0.000116	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—stomach cancer	4.5e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK8—stomach cancer	4.45e-06	0.000113	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NOS3—stomach cancer	4.3e-06	0.000109	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—stomach cancer	4.24e-06	0.000108	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—stomach cancer	4.11e-06	0.000104	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—stomach cancer	4.07e-06	0.000103	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NOS3—stomach cancer	4.05e-06	0.000103	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—stomach cancer	3.93e-06	9.99e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK3—stomach cancer	3.89e-06	9.88e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—stomach cancer	3.78e-06	9.61e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—stomach cancer	3.71e-06	9.42e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK1—stomach cancer	3.7e-06	9.4e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGFR—stomach cancer	3.7e-06	9.4e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KRAS—stomach cancer	3.49e-06	8.88e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	3.21e-06	8.15e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—stomach cancer	3.11e-06	7.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HRAS—stomach cancer	2.97e-06	7.54e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—stomach cancer	2.84e-06	7.22e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—stomach cancer	2.42e-06	6.15e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.28e-06	5.79e-05	CbGpPWpGaD
